Latest Asx News

Talga Group has successfully raised A$10 million through a strategic share placement to advance its Vittangi Anode Project, supported by key institutional investors and board members.

Aurum Resources reports significant shallow, high-grade gold intercepts at its Boundiali Gold Project in Côte d'Ivoire, underpinning ambitious drilling and resource expansion plans for 2025.

DMC Mining confirms its exploration permits in Guinea remain unaffected amid a government crackdown on non-compliant mining licences. The company welcomes regulatory reforms aimed at boosting investor confidence and is poised to start exploration once permits are granted.

Adavale Resources has reported a standout 22.2g/t gold assay from rock chip sampling at its newly defined Parkvale South prospect within the Parkes Project in NSW, highlighting a promising exploration advance ahead of planned drilling.

Dexus Industria REIT has upgraded its FY25 funds from operations guidance, citing lower finance costs and improved returns from Jandakot Airport. Distribution targets remain steady.

Nimy Resources has raised $2.75 million through a share placement to fast-track exploration and resource definition at its promising Block 3 gallium discovery in Western Australia amid soaring global gallium prices.

Verbrec Limited has landed over $11 million in new engineering and construction contracts, boosting its outlook for a solid profit in H2 FY2025 amid easing project deferrals.

Blue Star Helium has commenced drilling the State 9 well at its Galactica helium project in Colorado, marking a significant step in its helium development program. The well is progressing toward the Lyons Formation reservoir with plans for flow testing and production tie-in.

Microba Life Sciences reveals breakthrough data showing its MetaPanel™ test detects elusive gastrointestinal pathogens in 20% of chronic cases, enabling targeted treatment and complete symptom resolution.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.

Iltani Resources has raised $1.8 million through a share placement and launched a $1 million Share Purchase Plan to fund exploration at its promising Orient Silver-Indium Project.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.